Australian respiratory researchers have once again challenged the ongoing usefulness of asthma-COPD overlap syndrome (ACOS) as a disease entity. In an editorial in the European Respiratory Journal, Professors Vanessa McDonald and Peter Gibson from the Hunter Medical Research Institute suggested it was time to ditch the label. “In addition to ACOS we are now starting ...
Already a member?
Enter your email to keep reading.